Skip to main content

The biosafety incident response competence scale for clinical nursing staff: a development and validation study

Abstract

Aims

This study was designed to develop a biosafety incident response competence scale and evaluate its validity and reliability among clinical nurses.

Design

This study employed a sequential approach, comprising four phases: (1) the establishment of a multidimensional conceptual model, (2) the preliminary selection of the items, (3) further exploration and psychometric testing of the items, (4) the application of the scale among clinical nurses.

Methods

The biosafety incident response competence conceptual model was developed through literature review and the Delphi method. A total of 1,712 clinical nurses participated in the preliminary items selection, while 1,027 clinical nurses were involved in the further psychometric testing from July 2023 to August 2023. The item analysis, exploratory factor analysis and confirmatory factor analysis were conducted to evaluate the construct validity. Reliability was measured using Cronbach’s alpha, split-half reliability, and test-retest reliability, while validity analysis included content validity, structural validity, convergent validity, and discriminant validity. From September to November 2023, we conducted a survey using the established scale with a total of 4338 valid questionnaires collected. T-test and variance analysis was employed to determine potential variations in biosafety incident response competence based on participants characteristics.

Results

The final scale is composed of 4 factors and 29 items, including monitoring and warning abilities, nursing disposal abilities, biosafety knowledge preparedness, and infection protection abilities. The explanatory variance of the 4 factors was 75.100%. The Cronbach’s alpha, split-half reliability and test-retest reliability were 0.974, 0.945 and 0.840 respectively. The Scale-level content validity index was 0.866. The Average Variance Extracted of the 4 factors was larger than 0.5, the Construct Reliability was larger than 0.7, and the Heterotrait-Monotrait ratio were less than 0.9. There were significant differences in the scores of response competence among nurses of different ages, working years, titles, positions, departments, marital status and participation in biosafety training (all P < 0.05).

Conclusions

The biosafety incident response competence scale for nurses exhibits satisfactory reliability and validity, making it a valuable tool for assessing clinical nurses’ abilities in responding to biosafety incidents.

Peer Review reports

Introduction

Biosafety incidents encompass a range of biosafety issues caused by human incorrect and improper activities, as well as safety concerns arising from natural biological activities [1, 2]. These incidents include but not limited to infectious disease outbreaks, animal and plant epidemic, biotechnology incidents, laboratory biosafety accidents, biological weapons and bioterrorism attacks [1, 3]. The global climate change and increased globalization have led to a heightened concern regarding the rapid spread of emerging infectious diseases [4, 5]. Globalization has also accelerated the spread of pathogenic microorganisms and increased the pathogen transmission [6]. On the other hand, biological weapons threat humanity in infecting millions of people with a deadly disease [7, 8]. Alongside these factors, the widespread application and ongoing development of biotechnology in various fields have also led to concerns regarding its misuse and abuse [9]. All of these pose a threat to the biosecurity of humanity. As a crucial aspect of national security, the biosecurity directly impacts public health, long-term stability, and sustainable development [10]. Thus, biosecurity should be considered an integral part of overall national security [11]. It is crucial to enhance the system and capacity building of epidemic prevention and control and scientific research on public health [12]. In the past few years, many drawbacks have been exposed in the response to biosafety incidents such as COVID-19 Infectious Diseases and laboratory biosafety [13, 14]. Reviews of the outbreak and handling of the COVID-19 pandemic revealed weaknesses in early monitoring and warning systems for infectious disease outbreaks [15, 16].

The biosafety incident response competence refers to the emergency preparedness, monitoring and early warning, protection and control, and disposal capabilities that individuals possess when dealing with biosafety incidents, in order to cut off the spread and transmission of biosafety infections, avoid or reduce the consequences of diseases and deaths caused by biological threats [14]. As the medical workforce, nursing staff plays a vital role in biosafety incident prevention and response [17, 18]. Nurses with good biosafety event response capabilities can efficiently treat infected patients, contain the spread of biosafety infections, and to the largest extent minimize the disease severity [18]. Their response competence is not only related to biosecurity threat warning, but also related to the effectiveness of the biosafety infection treatment [19]. Given the impact on public health and social stability, the biosafety incident response competence of nursing staff holds immense significance [20]. Therefore, it is urgent to clarify and enhance clinical nurses’ biosafety incident response competence. However, there is a lack of specialized evaluation tools assessing nursing staff’s ability in responding to biosafety events, as well as a lack of investigation into the ability of clinical nursing staff to respond to biosafety events. The existing tools evaluating the response capacity of health personnel to biosafety incidents involve the Epidemic Preparedness Index (EPI) issued by Metabiota and the Global Health Security Index (GHSI) issued by Johns Hopkins University [21, 22]. Researchers use EPI and GHSI to assess the response capacity of health professionals in handling public health emergencies caused by infectious diseases [23, 24]. And Halcomb et al. [25] have developed the Brief Coping Orientation to Problems Experienced Scale for nurses during COVID-19. While this scale addresses coping strategies in the context of infectious disease incidents, it is crucial to acknowledge that biosafety incidents encompass broader aspects beyond infectious diseases. These instruments are insufficient to measure the biosafety incident response competence for clinical nursing staff. Therefore, relying solely on EPI and GHSI may not accurately gauge the biosafety incident response competence of nursing staff and Halcomb E’s scale is not sufficient to reflect the biosafety incident response competence for clinical nurses. Thus, there is a need for a quantifiable assessment tool specifically designed to evaluate the biosafety incident response competence for clinical nursing staff.

It is urgent to develop a specialized scale for assessing the ability of nursing staff to respond to biosafety events. Such a scale would play a crucial role in clarifying the current status of nursing staff’s biosafety event response ability. It would help identify existing shortcomings, pinpoint areas requiring improvement, and serve as a valuable reference for enhancing their preparedness and response capabilities for clinical nurses in future biosafety events.

The study

Aims

The aim of our study was to develop a biosafety incident response competence scale specifically tailored for clinical nurses and to assess its validity and reliability among.

Participants and sampling

Scale development and validation stage

We obtained permission from the administrative office of the hospital, and with their assistance, recruited clinical nurses from 7 tertiary hospitals in Shaanxi province, China by convenience sampling and the principle of voluntariness, from July 2023 to August 2023. The inclusion criteria required the clinical nurses to possess a nurse qualification certificate and engaged in clinical nursing work; Nurses who were unwilling to participate in the investigation or were not on duty during the data collection period were excluded from the study. The sample size was determined by the general rule of the factor analysis [26], which recommended an absolute sample size of at least 200 and a sample size-to-item ratio greater than 10, and a 5% sample loss rate. The first phase of the survey preliminarily explored the scale with a total of 49 items. Therefore, the sample size is N = (49 × 10) ÷ (1–5%) ≈ 516. In the second phase, which involved further exploration and evaluaion of the scale, there were a total of 33 items. Therefore, the sample size required for this phase is N = (33 × 10) ÷ (1–5%) ≈ 348. A total of 1,712 clinical nurses (for preliminary exploration of the item) and 1,027 clinical nurses (for further exploration and psychometric testing of the items) were finally recruited in our study.

Scale application stage

In the final phase of our study, we followed the same recruitment method as described previously. The final scale has 29 items, so the sample size required for this phase is N = (29 × 10) ÷ (1–5%) ≈ 305. From September to November 2023, we conducted a survey using the final scale and collected a total of 4338 valid questionnaires.

Design

From July 2023 to November 2023, we conducted a mixed-method study that focused on the development, validation, and application of the Biosafety Incident Response Competence Scale for clinical nurses. It involved 4 stages: (1) the construction of the biosafety incident response competence conceptual model for clinical nurses, (2) the preliminary exploration of the biosafety incident response competence scale, (3) further exploration and psychometric testing of the biosafety incident response competence scale, (4) the application of the biosafety incident response competence scale among clinical nurses. The flowchart is shown in Fig. 1.

Fig. 1
figure 1

The development procedure of the biosafety incident response competence scale for clinical nurses

The construction of the biosafety incident response competence conceptual model for clinical nurses

In the first stage, we constructed the first draft of the biosafety incident response competence conceptual model for clinical nurses by literature review, theoretical research, one-to-one face-to-face in-depth interviews and panel discussions. The data was analyzed by Colaizzi method of phenomena observation in qualitative study [27]. The transcribed interview sessions were analyzed by the coders using thematic analysis, which was conducted in three phases: initial coding, focused coding and thematic coding [28]. According to the qualitative interviews, literature review results obtained questionnaire content item pool of 4 primary indicators (Biosafety incident preparedness, Biosafety event monitoring abilities, Biosafety infection protection competence and Biosafety incident nursing abilities), 10 secondary indicators and 48 tertiary indicators.

Due to the need for multi-party collaboration in biosafety response, we have invited experts from multiple fields: epidemiology, prevention medicine, military health service and nursing, and those who are experienced in biosafety rescue for Delphi consultation. The inclusion criteria of consultation experts were as follows: (1) a minimum of 10 years of work experience; (2) possession of an intermediate or advanced level certificate; (3) voluntary participation in the investigation. Through Delphi expert consultation, the index system was scored and modified, and the percentage level of agreement was set to 80%. After the second round of consultation, the content of the conceptual model was unanimously recognized by experts. Kendall’s concordance coefficient was used to assess the degree of agreement among the experts. In the two rounds of Delphi consultation, Kendall’s W test had statistical significance (P<0.01), which means the experts were in agreement. A total of 17 items were modified, 3 items were deleted, 2 items were merged, 6 items were added, and 4 items were adjusted. This led to a final draft of a 49-item pool that incorporated the valuable input and consensus achieved through the Delphi consultation.

Preliminary exploration of the items

In the second stage, we compiled the index system into the ‘clinical nurses’ biosafety incident response competence’ preliminary scale which included 49 items through the expert meeting. Experts transform the semantics of the conceptual model into the semantics of the scale. According to the type of questions, the Likert type responding was chosen. Once the type of Likert tool has been selected, the researcher must determine the number of Likert response options spectrum classes. In total, there is no standard guidelines for the number of response options on a Likert [29]. Since the 5-point scale form was most commonly chosen as the easiest to complete, and item omission was least frequent [30, 31], we adopted the Likert 5-level scoring method (Completely do not understand = 1, Not quite understand = 2, General = 3, Understand = 4, Very familiar = 5). Before the formal investigation, the preliminary scale was distributed to clinical nurses to ensure that the scale was easy to understand and could be used for formal investigation.

In the first round of investigation, 1,712 clinical nurses participated in the survey using the preliminary scale. Critical ratio, discrete trend, correlation coefficient, factor loading, Cronbach’s α coefficient were adopted for item analysis [32]. Exploratory factor analysis was conducted, which includes Kaiser-Meyer-Olkin analysis and factor extraction and rotation [32]. Based on the results of item analysis and exploratory factor analysis, a filtering process was undertaken to refine the items. A preliminary scale was then drafted, consisting of 4 factors (Biosafety event monitoring and warning abilities, Biosafety incident nursing disposal abilities, Biosafety knowledge preparedness and Biosafety infection protection abilities) and 33 items, basically consistent with the previous index system.

Further exploration and psychometric testing of the items

In the third stage, we conducted the second round of questionnaire survey which included 1,027 clinical nurses. Item analysis was performed to filter out the remaining 33 items. Additionally, exploratory factor analysis and confirmatory factor analysis were employed to re-explore and verify the structure of the scale. And we adopted reliability test and validity test to inspect the reliability and validity of the scale. Reliability analysis included measures such as test-retest reliability, Cronbach’s alpha, split-half reliability, and validity analysis included content validity, structure validity, convergent validity, discriminant validity. The sample size of 1,027 participants was randomly divided, with 514 questionnaires used for exploratory factor analysis and 513 questionnaires used for confirmatory factor analysis. Finally, the biosafety incident response competence scale with high reliability and validity was developed. The scale consisted of 4 dimensions and 29 items, offering a comprehensive assessment tool for evaluating clinical nurses’ abilities in responding to biosafety incidents.

The application of the final scale

In the fourth stage, we used the final scale to conduct the third round of questionnaire survey which included 4,338 clinical nurses. T-test and analysis of variance were used to compare the competence of nurses with different demographic characteristics to determine whether variations in biosafety incident response competence exist based on participant characteristics.

Data collection

Prior to commencing the formal investigation, the researchers underwent comprehensive training on conducting the questionnaire survey. We then obtained permission from their admin office of the hospital to contact nurses by emails to distribute the electronic questionnaires. Written informed consents were obtained from the participants by electronic notification issued through email prior to conducting the study. The time for the questionnaire completion was controlled within 5 to 10 min. According to voluntary principle, we recruited 1,800 clinical nurses in the first round of investigation using convenient sampling method. A total of 1,712 valid questionnaires were collected, with a response rate of 95.11%. In the second round of investigation, 1,100 questionnaires were distributed, with 1,027 valid ones collected, leading to a response rate of 93.36%. In the third round of investigation, 4,600 questionnaires were distributed, with 4,338 valid ones collected, resulting in a response rate of 94.30%.

Data analysis

We analyzed the data by SPSS 26.0 and Mplus 8.3. For the critical ratio, the total score of the scale was ranked from high to low, and the relationship between the top 27% and the bottom 27% was analyzed to determine the discrimination of the scale. The standard deviation of item scores represented the degree of dispersion. Items with a standard deviation below 0.85 were considered poor discriminators and recommended for removal [33]. The significant correlation coefficient indicates a strong correlation between the item and the scale. For the factor loading, if the total score is less than 0.4, the item needs to be deleted [34, 35]. And if Cronbach’s α becomes larger after deleting the item, it should be deleted [36]. For reliability analysis, we used Cronbach’s α coefficient, split-half reliability and test-retest reliability [37]. For validity analysis, we used content validity analysis, convergent validity, discriminant validity and structure analysis, which contained exploratory factor analysis and confirmatory factor analysis [38]. Content validity was assessed by the Item-level content validity index (I-CVI) and Scale-level content validity index (S-CVI). Structure validity was assessed by confirmatory factor analysis. Convergent validity was assessed by the Average Variance Extracted (AVE) and Construct Reliability (CR). Discriminant validity was assessed with the criterion of the heterotrait-monotrait ratio (HTMT). We used alpha ≤ 0.05 as the statistical difference evaluation standard.

Results

Characteristics of the participants

In the first round of investigation, the average age of clinical nursing staff was (32.25 ± 6.48) years old. In the second round of the survey, the average age of clinical nurses was (33.09 ± 6.36) years old. In the third round of the survey, the average age of clinical nurses was (34.03 ± 7.30) years old. Other Demographic features are shown in Table 1.

Table 1 General demographic data. N, number

Preliminary exploration of the scale

Item analysis

As shown in Table 2, the results of item analysis of the 1,712 questionnaires to preliminary explore the scale in the first round showed that the values of each item in item analysis were up to the standard and all the items were to be reserved.

Table 2 The item analysis for clinical nurses’ biosafety incident response competence scale

Exploratory factor analysis

Based on the item analysis, exploratory factor analysis was employed to preliminarily identify the structure of the nursing staff’s biosafety incident response competence scale.

Kaiser-Meyer-Olkin (KMO) analysis

The KMO value was 0.984, the Bartley Sphericity test was statistically significant (χ2 = 99,415.926, df = 1,176, P < 0.001), indicating that 49 items of nursing staff’s biosafety incident response competence scale had common factors and were suitable for factor analysis.

Factor extraction and rotation

When extracting and rotating factors, we removed the highest factor load less than 0.4, factor load across two or more factors and the difference less than 0.2, and the number of common factors included items less than 3 [39]. According to the delete criteria, items 8, 9, 10, 14, 21, 26, 27, 31, 34, 35, 36, 37, 38, 39, 40, 41 were deleted, and 4 common factors were extracted. The cumulative contribution of variance accounted for 73.427%.

Based on the item analysis and exploratory factor analysis, a preliminary scale of nursing staff’s biosafety incident response competence was developed, which includes 4 factors and 33 items. 4 factors were named at the group meeting as follows: biosafety knowledge preparedness, biosafety event monitoring and warning abilities, biosafety infection protection abilities and biosafety incident nursing disposal abilities, as shown in Table 3.

Table 3 Factor matrix of clinical nurses’ biosafety incident response competence scale (n = 1,712)

Further exploration and psychometric testing of the scale

Item analysis

In this section, the same method for item analysis was employed to assess the performance of each item. The results showed that item 21 met the deletion criteria and was intended to be deleted after discussion by the research group, and other items need to be reserved, as shown in Table 2.

Exploration of scale structure

Based on the results of the item analysis, we proceeded to conduct further exploration of the scale’s structure. The scree plot of exploratory factor analysis shows clear inflection points between components 3 ~ 5 in the scale. Based on the initial structure of the conceptual model, a 4-factor model was preliminarily extracted, as shown in Fig. 2.

Fig. 2
figure 2

Scree plot of exploratory factor analysis for nursing staff’s biosafety incident response competence scale (n = 1,027)

We randomly selected 514 questionnaires from the 1,027 questionnaires, and exploratory factors were analyzed by principal component analysis. Bartlett sphericity test yielded a value of 16,383.411, and the KMO test value was 0.970 (P < 0.01). The results showed that the eigenvalues of the 4 factors were 17.925, 2.798, 1.491 and 1.128, and the variance contribution rates were 56.015%, 8.744%, 4.658% and 3.524%. The cumulative contribution of variance rate was 72.941%. However, item 9 " Regularly participate in the education of biosafety-related science knowledge “, 8 " Regularly participate in biosafety medical rescue exercises and training and joint military and civilian rescue exercises to deal with emergencies “, and 10 " Regularly pay attention to the biosafety frontier, and regularly participate in the training of biosafety nursing skills " were classified as the first common factor, falling into the same category as items 19, 18, 17, 15, 12, 11, 13, 14, and 20, given that common factor 1 corresponds to the model’s “monitoring and warning ability”. Considering that items 8, 9, and 10 do not belong to the same category as factor 1, ‘Biosafety event monitoring and warning abilities’, the research group deleted items 8–10 after discussion.

On the basis of preliminary exploratory factor analysis, the scale included 4 dimensions and 29 items. To further investigate the factor structure, another round of exploratory factor analysis was conducted using a randomly selected subset of 514 questionnaires from the pool of 1,027 valid questionnaires. The results showed that the Bartlett sphericity test value of the scale was 30,410.372, and the KMO test value was 0.973 (P < 0.01). The characteristic values of the four factors are 16.885, 2.370, 1.436, and 1.088, respectively, with variance contribution rates of 58.224%, 8.174%, 4.950%, and 3.751%, and cumulative variance contribution rate of 75.100%. The cumulative variance contribution rate had been improved compared to the preliminary exploratory factor analysis. Importantly, the items included in each of the four factors aligned well with the theoretical model, as depicted in Table 4. The finalized version of the scale can be found in the Supplementary file.

Table 4 Factor load of formal scale (29 items)

Reliability analysis

The scale and its 4 dimensions demonstrated good reliability. The overall internal consistency was 0.974, and that of each dimension ranged from 0.888 to 0.964. The total split-half reliability was 0.885, and of each dimension ranged from 0.856 to 0.917. To ensure comparability, we randomly selected 10% of the nursing staff and labeled them, and compared the selected nursing staff with the general nurses in Demography data, the difference was not significant (P > 0.05), indicating that the samples were comparable with the general samples. A questionnaire study was conducted among 10% of these nursing staff who were distributed with the scale again after a 2 weeks interval. The results showed that the total retest reliability of the scale was 0.840, and the retest reliability of each dimension was 0.696 to 0.881, as shown in Table 5.

Table 5 Reliability coefficient of clinical nurses’ biosafety incident response competence scale

Validity analysis

Content validity

Fifteen experts in the field of biosafety were invited to evaluate the content validity of the scale. The results showed that the Item-level content validity index (I-CVI) was 0.800 to 0.933, and Scale-level content validity index (S-CVI) was 0.866.

Structure validity

The remaining 513 questionnaires in the second round of investigation were selected for confirmatory factor analysis. The 4-factor model was fitted by the maximum likelihood estimation method. The fitting indexes were shown in Table 6, and the standard factor load model formed by confirmatory factor analysis was shown in Fig. 3. The factor load of each item was greater than 0.40, and all items had statistical significance (P < 0.05), indicating that the questionnaire had favorable structural validity.

Fig. 3
figure 3

Standardized 4-factor structural model of nursing staff’s biosafety incident response competence scale (n = 513). BEMWA = Biosafety event monitoring and warning abilities; BINDA = Biosafety incident nursing disposal abilities; BKP = Biosafety knowledge preparedness; BIPA = Biosafety infection protection abilities

Table 6 Confirmatory factor analysis model fitting values

Convergent validity

Convergent validity was assessed by the Average Variance Extracted (AVE) and Construct Reliability (CR). AVE above 0.5 and CR above 0.7 were considered evidence of convergent validity. AVE was larger than 0.5 for both Biosafety event monitoring and warning abilities (AVE = 0.502), Biosafety incident nursing disposal abilities (AVE = 0.524), Biosafety knowledge preparedness (AVE = 0.508) and Biosafety infection protection abilities (AVE = 0.515) attesting the convergent validity of all the first order constructs [40, 41] (See Table 7).

Table 7 Convergent validity evidence of the scale

Discriminant validity

Evidence of discriminant validity between first order constructs was assessed with the criterion of the heterotrait-monotrait ratio (HTMT). HTMT below 0.9 was considered evidence of discriminant validity [42]. According to the HTMT, more liberal criterion discriminant validity was observed between the 4 engagement constructs (See Table 8).

Table 8 Heterotrait-Monotrait ratio of discriminant validity evidence

The application of the scale

T-test and analysis of variance showed significant differences in the scores of response competence among clinical nurses of different ages, working years, titles, positions, department, marital status and participation in biosafety related training (all P < 0.05) (See Table 9).

Table 9 Comparison of biosafety incident response competence of clinical nurses with different demographic characteristics (N = 4,338)

Discussion

The biosafety incident response competence scale for clinical nurses was developed using a rigorous scientific approach. A conceptual model was created based on literature review, qualitative interviews, group meetings, and Delphi consultation. The research group used the Classic Test Theory (CTT) to assess item quality, including measures such as critical ratio, discrete trend, the correlation coefficient, factor loading and Cronbach’s α coefficient [43, 44]. On the basis of the conceptual model, the structure of the scale was examined, and its reliability and validity were tested. The final version of scale consisted of 4 dimensions and 29 items, demonstrating favorable reliability and validity. The cumulative variance contribution rate of the 4 factors in the scale amounted to 75.100%, indicating that these 4 factors could adequately explain the variation in biosafety incident response competence of clinical nurses to the extent of 75.100%. Reliability analysis refers to the consistency, stability, and reliability of test results [45]. Validity analysis refers to the validity of the results, that is, the consistency between the measurement results and the content to be examined [46]. The reliability and the validity test of the scale shows that it has good reliability and validity, which also reflects the scientific process of scale development. The results of research on the application of the scale showed that there were significant differences in the scores of response competence among nurses of different ages, working years, titles, positions, department, marital status and whether participated in biosafety related training, which further validated the effectiveness of the scale.

The scale developed in our study measures the biosafety incident response competence of nursing staff across four dimensions: biosafety event monitoring and warning abilities, biosafety incident nursing disposal abilities, biosafety knowledge preparedness, and biosafety infection protection abilities. The scale adopts Likert’s 5-level scoring method, where higher scores reflect a greater level of biosafety incident response competence among nursing staff. The scale developed in our study fills the existing gap in assessing the ability of nursing staff to respond to biosafety incidents by providing a much-needed measurement tool.

Currently, the world is facing various biosecurity threats, including emerging infectious diseases, bioterrorism attacks, and the potential use of biological weapons [47]. The recurrence of public health emergencies and safety incidents such as COVID-19 and other emerging infectious diseases underscored the significance of biosafety [48]. Meanwhile, the escalating safety risks associated with the misuse and abuse of new dual-use biotechnology have drawn unprecedented global attention to biosafety issues[49]. Nursing staff are at the forefront of clinical care, directly engaging with patients. They are not only “sentries” who discover dangerous situations, but also the first “shield” to deal with threats [50]. Therefore, quantifying their ability to respond to biosafety incidents is crucial [51, 52].

Biosafety event monitoring and warning abilities dimension includes 9 items. Biosafety incidents are hidden and uncertain, which will lead to serious consequences if not identified timely [53]. Therefore, clinical nurses need to possess strong monitoring and warning capabilities to identify biosafety risks. Biosafety incident nursing disposal abilities dimension includes 8 items. In the event of a biosafety incident, nursing staff with proficient nursing disposal abilities can swiftly carry out rescue operations, contributing to disease containment and promoting patient recovery [54, 55]. Research showed that good nursing disposal ability could achieve timely treatment of patients [56]. Biosafety knowledge preparedness dimension includes 7 items. Currently, biosafety has emerged as a critical aspect of national security, and everyone needs to basically acquire biosafety knowledge [2, 57]. Existing research shows that caregivers lack preparedness when dealing with emergencies and disasters [58]. Therefore, it is essential for clinical nurses, particularly those specializing in biosafety nursing, to acquire comprehensive knowledge of biosafety. As crucial participants in managing biosafety incidents, nursing staff should possess systematic knowledge of biosafety to effectively respond to such threats [59]. Biosafety infection protection abilities dimension includes 5 items. A study of SARS-CoV-2 infection among healthcare workers in Colombia shown that medical personnel are susceptible to infections while responding to infectious diseases [60]. Due to the fact that most biosafety incidents can be contagious, nursing staff also need to prioritize self-protection during rescue operations and maintain a strong preventive mindset [61]. The biosafety guidance is intended to provide insights to nurses regarding the proper methods of handling the blood and other body fluid samples for biochemical investigations concerning the proper methods of sample collection, transport, processing, and disposal [50].

The dimensions of the scale and the abilities in the items cover each stage of nursing staff’s biosafety event rescue, providing detailed content to effectively assess their competence in responding to biosafety events. This scale can serve as a valuable tool for assessing, evaluating, and training nursing staff in biosafety event response. In future research, we can use this scale to measure the biosafety incident response competence of clinical nurses, identify their weaknesses, and carry out targeted training to improve their biosafety incident response competence.

Our research also has certain limitations. In our study, we didn’t conduct cross-group measurement invariance analysis on nurses from different levels of hospitals and departments. So, it remains unclear whether there were differences in its application among different groups with distinct characteristics.

Conclusion

The present study explained the steps we took to develop a new tool to measure the biosafety incident response competence for clinical nurses. The final scale is composed of 4 factors and 29 items, including monitoring and warning abilities, nursing disposal abilities, biosafety knowledge preparedness, and infection protection abilities. The exploration method, psychometric testing, reliabilition and validition approaches we used (item analysis, exploratory factor analysis, Cronbach’s alpha, split-half reliability, test-retest reliability, content validity, structure validity, convergent validity, discriminant validity) provided justification for the satisfactory reliability and validity.

Availability of data and materials

The datasets generated and analyzed during the current study are not publicly available due to the protection of the privacy of clinical nurses but are available from the corresponding author (906963251@qq.com) on reasonable request.

References

  1. Weiss S, Yitzhaki S, Shapira SC. Lessons to be learned from recent biosafety incidents in the United States. Isr Med Assoc J. 2015;17:269–73.

    PubMed  Google Scholar 

  2. Zhou D, et al. Biosafety and biosecurity. J Biosaf Biosecur. 2019;1:15–8. https://doi.org/10.1016/j.jobb.2019.01.001.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zhang EM, et al. Emergency response for a laboratory biosafety incident. Biomed Environ Sci. 2019;32:231–3. https://doi.org/10.3967/bes2019.032.

    Article  PubMed  Google Scholar 

  4. Ellwanger JH, Kaminski VL, Chies JAB. Emerging infectious disease prevention: where should we invest our resources and efforts? J Infect Public Health. 2019;12:313–6. https://doi.org/10.1016/j.jiph.2019.03.010.

    Article  PubMed  Google Scholar 

  5. Baddal B, Editorial. Emerging technologies in infectious disease treatment, prevention and control. Front Cell Infect Microbiol. 2022;12:1096998. https://doi.org/10.3389/fcimb.2022.1096998.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Semenza JC, Rocklöv J, Ebi KL. Climate change and cascading risks from infectious disease. Infect Dis Ther. 2022;11:1371–90. https://doi.org/10.1007/s40121-022-00647-3.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gronvall GK, et al. The Biological weapons Convention should endorse the Tianjin Biosecurity Guidelines for Codes of Conduct. Trends Microbiol. 2022;30:1119–20. https://doi.org/10.1016/j.tim.2022.09.014.

    Article  CAS  PubMed  Google Scholar 

  8. Pohanka M. Immunosensors for assay of toxic biological warfare agents. Biosensors. 2023;13. https://doi.org/10.3390/bios13030402.

  9. McCarty NS, Ledesma-Amaro R. Synthetic Biology tools to engineer Microbial communities for Biotechnology. Trends Biotechnol. 2019;37:181–97. https://doi.org/10.1016/j.tibtech.2018.11.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hao R, et al. Surveillance of emerging infectious diseases for biosecurity. Sci China Life Sci. 2022;65:1504–16. https://doi.org/10.1007/s11427-021-2071-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Stone M. Biosecurity is critical to New Zealand’s national security, economy and way of life. N Z Vet J. 2021;69:309–12. https://doi.org/10.1080/00480169.2021.1965076.

    Article  PubMed  Google Scholar 

  12. Boyd M, Baker MG, Nelson C, Wilson N. The 2019 Global Health Security Index (GHSI) and its implications for New Zealand and Pacific regional health security. N Z Med J. 2020;133:83–92.

    PubMed  Google Scholar 

  13. Barkia A, Laamrani H, Belalia A, Benmamoun A, Khader Y. Morocco’s national response to the COVID-19 pandemic: public health challenges and lessons learned. JMIR Public Health Surveill. 2021;7:e31930. https://doi.org/10.2196/31930.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Frater JL, Anderson J. The impact of biosafety enhancement on stat laboratory quality metrics: lessons from the COVID-19 pandemic. Clin Chim Acta. 2021;512:58–62. https://doi.org/10.1016/j.cca.2020.11.021.

    Article  CAS  PubMed  Google Scholar 

  15. Zhu Y, et al. Early warning of COVID-19 via wastewater-based epidemiology: potential and bottlenecks. Sci Total Environ. 2021;767:145124. https://doi.org/10.1016/j.scitotenv.2021.145124.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  16. Stow D, Barker RO, Matthews FE, Hanratty B. National early warning scores and COVID-19 deaths in care homes: an ecological time-series study. BMJ Open. 2021;11:e045579. https://doi.org/10.1136/bmjopen-2020-045579.

    Article  PubMed  Google Scholar 

  17. Kinlay SH, et al. Novel Deployment of Pediatric Biocontainment Unit nurses in response to COVID-19. Am J Nurs. 2021;121:53–8. https://doi.org/10.1097/01.NAJ.0000799008.92892.b4.

    Article  PubMed  Google Scholar 

  18. Wu C, et al. Construction of an index system of core competence assessment for infectious disease specialist nurse in China: a Delphi study. BMC Infect Dis. 2021;21:791. https://doi.org/10.1186/s12879-021-06402-2.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Saseedharan S, Karanam R, Kadam V, Shirsekar S. Smart secretion management to protect nurses from COVID19 and other infectious diseases. Nurs Crit Care. 2022;27:706–10. https://doi.org/10.1111/nicc.12586.

    Article  PubMed  Google Scholar 

  20. Bajjou T, et al. Role of training and experience in biosafety practices among nurses working in level 2 or 3 patient containment. Appl Biosaf. 2020;25:96–103. https://doi.org/10.1177/1535676019899506.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Oppenheim B, et al. Assessing global preparedness for the next pandemic: development and application of an epidemic preparedness index. BMJ Glob Health. 2019;4:e001157. https://doi.org/10.1136/bmjgh-2018-001157.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ravi SJ, et al. The value proposition of the Global Health Security Index. BMJ Global Health. 2020;5. https://doi.org/10.1136/bmjgh-2020-003648.

  23. Zhang XX, et al. Towards a global one Health index: a potential assessment tool for one health performance. Infect Dis Poverty. 2022;11. https://doi.org/10.1186/s40249-022-00979-9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Khalifa BA, et al. The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2021;113:7–11. https://doi.org/10.1016/j.ijid.2021.09.034.

    Article  CAS  Google Scholar 

  25. Halcomb E, et al. Evaluation of the brief coping orientation to problems experienced scale and exploration of coping among primary health care nurses during COVID-19. J Nurs Adm Manag. 2022;30:2597–608. https://doi.org/10.1111/jonm.13816.

    Article  Google Scholar 

  26. Yang Z, Wang H, Wang A. Development and validation of the advance care planning practice preference scale for clinical nurses. J Adv Nurs. 2023;79:2695–708. https://doi.org/10.1111/jan.15641.

    Article  PubMed  Google Scholar 

  27. Vignato J, Inman M, Patsais M, Conley V. Computer-assisted qualitative data analysis software, phenomenology, and colaizzi’s method. West J Nurs Res. 2022;44:1117–23. https://doi.org/10.1177/01939459211030335.

    Article  PubMed  Google Scholar 

  28. Smith A, McDonald AD, Sasangohar F. Night-shift nurses and drowsy driving: a qualitative study. Int J Nurs Stud. 2020;112:103600. https://doi.org/10.1016/j.ijnurstu.2020.103600.

    Article  PubMed  Google Scholar 

  29. Atashzadeh-Shoorideh F, Parvizy S, Hosseini M, Raziani Y, Mohammadipour F. Developing and validating the nursing presence scale for hospitalized patients. BMC Nurs. 2022;21:138. https://doi.org/10.1186/s12912-022-00896-0.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Nagata C, Ido M, Shimizu H, Misao A, Matsuura H. Choice of response scale for health measurement: comparison of 4, 5, and 7-point scales and visual analog scale. J Epidemiol. 1996;6:192–7. https://doi.org/10.2188/jea.6.192.

    Article  CAS  PubMed  Google Scholar 

  31. Preston CC, Colman AM. Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. Acta Psychol. 2000;104:1–15. https://doi.org/10.1016/s0001-6918(99)00050-5.

    Article  CAS  Google Scholar 

  32. Wu C, et al. Development, reliability and validity of infectious disease specialist Nurse’s Core competence scale. BMC Nurs. 2021;20. https://doi.org/10.1186/s12912-021-00757-2.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Linderman MD, et al. Development and validation of a Comprehensive Genomics Knowledge Scale. Public Health Genomics. 2021;24:291–303. https://doi.org/10.1159/000515006.

    Article  PubMed  Google Scholar 

  34. Yoshida K. Development and validation of a Disease-Specific Oromandibular Dystonia Rating Scale (OMDRS). Front Neurol. 2020;11:583177. https://doi.org/10.3389/fneur.2020.583177.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Mandarakas MR, et al. Development and validation of the Charcot-Marie-tooth Disease Infant Scale. Brain. 2018;141:3319–30. https://doi.org/10.1093/brain/awy280.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dibb B, Golding SE, Dozier TH. The development and validation of the Misophonia response scale. J Psychosom Res. 2021;149:110587. https://doi.org/10.1016/j.jpsychores.2021.110587.

    Article  CAS  PubMed  Google Scholar 

  37. Pronk T, Molenaar D, Wiers RW, Murre J. Methods to split cognitive task data for estimating split-half reliability: a comprehensive review and systematic assessment. Psychon Bull Rev. 2022;29:44–54. https://doi.org/10.3758/s13423-021-01948-3.

    Article  PubMed  Google Scholar 

  38. Zhang S, Zang X, Zhang F. Development and validation of the Win-Win Scale. Front Psychol. 2021;12:657015. https://doi.org/10.3389/fpsyg.2021.657015.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Matsumura K, Hamazaki K, Tsuchida A, Kasamatsu H, Inadera H. Factor structure of the Edinburgh Postnatal Depression Scale in the Japan Environment and Children’s study. Sci Rep. 2020;10:11647. https://doi.org/10.1038/s41598-020-67321-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lazemi Z, Barkhordari-Sharifabad M. Translation and psychometric evaluation of the persian version of the nursing Profession Self-Efficacy Scale. BMC Nurs. 2023;22. https://doi.org/10.1186/s12912-023-01182-3.

  41. Lu X, et al. Development and initial validation of the psychological capital scale for nurses in Chinese local context. BMC Nurs. 2023;22:28. https://doi.org/10.1186/s12912-022-01148-x.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Sharif-Nia H, et al. Psychometrics evaluation of the university student engagement inventory in online learning among arab students. BMC Nurs. 2023;22:158. https://doi.org/10.1186/s12912-023-01318-5.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Lee MK, et al. Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks. Qual Life Res. 2023;32:1355–67. https://doi.org/10.1007/s11136-022-03255-3.

    Article  PubMed  Google Scholar 

  44. Rodriguez-Blazquez C, Forjaz MJ, Ayala A, Portillo MC, Ambrosio L. Living with chronic illness scale: International validation through the classic test theory and Rasch analysis among spanish-speaking populations with long-term conditions. Health Expect. 2021;24:2065–77. https://doi.org/10.1111/hex.13351.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Keyworth C, Epton T, Goldthorpe J, Calam R, Armitage CJ. Acceptability, reliability, and validity of a brief measure of capabilities, opportunities, and motivations (COM-B). Br J Health Psychol. 2020;25:474–501. https://doi.org/10.1111/bjhp.12417.

    Article  PubMed  Google Scholar 

  46. Tanrıverdi E, Nas MA, Kaşali K, Layık ME, El-Aty AMA. Validity and reliability of the professionalism assessment scale in Turkish medical students. PLoS One. 2023;18:e0281000. https://doi.org/10.1371/journal.pone.0281000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Cummings CL, et al. Emerging biosecurity threats and responses: a review of published and gray literatures. Books and Documentsr. 2021. p. 13–36. https://doi.org/10.1007/978-94-024-2086-9_2.

  48. Pilkington EH, et al. From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021;131:16–40. https://doi.org/10.1016/j.actbio.2021.06.023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Volk KM, Gering TJ. Predicting biosecurity threats: deployment and detection of biological weapons. Books and Documents. 2021. p. 195–207. https://doi.org/10.1007/978-94-024-2086-9_13.

  50. Niraula A, Gelal B, Lamsal M. Approach to Sample Collection, Transport and Processing of suspected or confirmed COVID-19 patients for Biochemistry investigations. JNMA. 2020;58:1107–11. https://doi.org/10.31729/jnma.5705.

    Article  Google Scholar 

  51. Kirino Y, et al. Seroprevalence of severe fever with thrombocytopenia syndrome virus in small-animal veterinarians and nurses in the Japanese prefecture with the highest case load. Viruses. 2021;13. https://doi.org/10.3390/v13020229.

  52. Rojas-Perez HL, et al. Nurses’ environmental practices in Northern Peruvian hospitals. Workplace Health Saf. 2024;72:68–74. https://doi.org/10.1177/21650799231163130.

    Article  PubMed  Google Scholar 

  53. Devaux CA. The hidden face of academic researches on classified highly pathogenic microorganisms. Infect Genet Evolution: J Mol Epidemiol Evolutionary Genet Infect Dis. 2015;29:26–34. https://doi.org/10.1016/j.meegid.2014.10.028.

    Article  Google Scholar 

  54. Chen CC, Chi CY. Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: perspectives from Taiwan. Cancer Cytopathol. 2020;128:309–16. https://doi.org/10.1002/cncy.22280.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Huang LH, Chen CM, Chen SF, Wang HH. Roles of nurses and National nurses associations in combating COVID-19: Taiwan experience. Int Nurs Rev. 2020;67:318–22. https://doi.org/10.1111/inr.12609.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Li N, et al. Prospective study on application of mind mapping combined with scenario simulation training on the ability training of junior nurses in hospital transfer of patients with critical burns and trauma. Zhonghua Shao Shang Za Zhi. 2023;39:465–71. https://doi.org/10.3760/cma.j.cn501225-20220524-00200.

    Article  CAS  Google Scholar 

  57. Shehri AA, Al-Sulaiman S, Azmi AM, S., Alshehri SS. Bio-safety and bio-security: a major global concern for ongoing COVID-19 pandemic. Saudi J Biol Sci. 2022;29:132–9. https://doi.org/10.1016/j.sjbs.2021.08.060.

    Article  CAS  Google Scholar 

  58. Wang Y, et al. Disaster preparedness among nurses in China: a cross-sectional study. J Nurs Res. 2023;31:e255. https://doi.org/10.1097/jnr.0000000000000537.

    Article  ADS  PubMed  Google Scholar 

  59. Fryk JJ, et al. Knowledge, attitudes and practices of healthcare workers within an Australian tertiary hospital to managing high-consequence infectious diseases. Infect Dis Health. 2021;26:95–103. https://doi.org/10.1016/j.idh.2020.10.002.

    Article  PubMed  Google Scholar 

  60. Rodriguez-Lopez M, et al. A case-control study of factors associated with SARS-CoV-2 infection among healthcare workers in Colombia. BMC Infect Dis. 2021;21. https://doi.org/10.1186/s12879-021-06581-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Hofmeyer A, Taylor R. Strategies and resources for nurse leaders to use to lead with empathy and prudence so they understand and address sources of anxiety among nurses practising in the era of COVID-19. J Clin Nurs. 2021;30:298–305. https://doi.org/10.1111/jocn.15520.

    Article  PubMed  Google Scholar 

  62. Ballantyne A, Eriksson S. Research ethics revised: the new CIOMS guidelines and the world medical association declaration of Helsinki in context. Bioethics. 2019;33:310–1. https://doi.org/10.1111/bioe.12581.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We extend our gratitude to the nurses participating in the study for their support and cooperation.

Funding

Construction of a Virtual Simulation Training Platform for Nursing Rescue under the Background of Biosafety Defense (145AHQ080005002X); Shaanxi Province General Project - Social Development Field (2024SF-YBXM-666); Doctoral Dissertation Project Funding of Air Force Medical University (2023D05); Project Establishment and Cultivation of Teaching Achievements at the School Level of Air Force Medical University (JXCG2023PY19); Military Nursing Innovation Special Plan (2023HL008).

Author information

Authors and Affiliations

Authors

Contributions

CW, HLZ and YJZ contributed to the research design, data analysis and writing of the paper. MYH and YWL distributed and withdrew the questionnaires. JH was in charge of writing the paper and verifying the English version. SWL and YLZ were responsible for analyzing the data while HJL was for designing the research and providing guidance from the perspective of statistics. All authors have read and approved the manuscript.

Corresponding authors

Correspondence to Shuwen Li, Yulian Zhang or Hong-juan Lang.

Ethics declarations

Ethics approval and consent to participate

The study was conducted in accordance with the Helsinki Declaration [62]. Research was approved by the ethics committee of Air Force Medical University (KY20224143-1). Informed consent was obtained from all participants included in the study and they were assured that the questionnaires would only be used for research. They could withdraw from the study at any time for any reason.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, C., Zhang, H., Zhang, Y. et al. The biosafety incident response competence scale for clinical nursing staff: a development and validation study. BMC Nurs 23, 180 (2024). https://doi.org/10.1186/s12912-024-01848-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12912-024-01848-6

Keywords